Updated Jul 16, 2026
Camaisa Allan is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $19K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-17 | CLDI | Calidi Biotherapeutics, Inc. | S — Open-market sale | 850 | $1.46 | $1K |
| 2025-12-16 | CLDI | Calidi Biotherapeutics, Inc. | S — Open-market sale | 850 | $1.46 | $1K |
| 2024-12-18 | CLDI | Calidi Biotherapeutics, Inc. | S — Open-market sale | 10.0K | $1.62 | $16K |
Camaisa Allan is a corporate insider — currently tracked as Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($19K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Camaisa Allan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.